Trent Campbell

Vice President, Commercial Strategy & Operations at Axonics

Trent Campbell has over 15 years of experience in sales and business development roles. Trent is currently serving as the Vice President of Market Growth at Axonics, Inc., where they have successfully developed go-to-market strategies, executed launch plans, and achieved rapid growth of a new implantable sacral neuromodulation system. Trent has also created key strategies for selling surgical devices to healthcare providers, including targeting health systems, developing corporate presentations and messaging, and implementing a sustainable pricing model. Prior to this, Trent worked as the Director of National Accounts at Fisher & Paykel Healthcare, where they led sales growth, managed a large contract portfolio, and implemented a new commercialization strategy. Trent also held positions at Applied Medical and Atrium Medical/Maquet Getinge Group, where they directed negotiations, managed contract portfolios, and developed healthcare economic models. Trent began their career at ADP as a District Manager, where they achieved significant sales success and earned multiple awards. Overall, Trent's experience demonstrates a strong track record of driving sales growth, developing strategic partnerships, and managing large contract portfolios.

Trent Campbell completed their Bachelor of Arts degree at Maranatha Baptist University from 2001 to 2005. Subsequently, they pursued a Master of Arts (MA) degree at Heart of America Seminary from 2005 to 2007. In terms of certifications, Trent obtained several through Johns Hopkins University via Coursera. In October 2023, they completed "A Crash Course in Data Science" and "Building a Data Science Team." In November 2023, they obtained certifications in "Data Science in Real Life" and "Managing Data Analysis."

Location

Aliso Viejo, United States

Links

Previous companies


Org chart


Teams


Offices


Axonics

2 followers

Axonics® is dedicated to improving the quality of life of people suffering from bladder and bowel dysfunction, conditions that impact the lives of tens of millions of adults globally. The Company’s products include the Axonics Sacral Neuromodulation System designed to treat overactive bladder and fecal incontinence and the Bulkamid® hydrogel designed to treat women with stress urinary incontinence.


Industries

Employees

201-500

Links